Skip to Main Content
Contributors
++

Numbers in brackets refer to the chapter(s) written or co-written by the contributor.

++
++

James L. Abbruzzese, MD

++

Chief, Division of Medical Oncology,

++

Department of Medicine; Associate Director,

++

Clinical Research, Duke Cancer Institute,

++

Durham, North Carolina [49]

++
++

John W. Adamson, MD

++

Clinical Professor,

++

Division of Hematology/Oncology,

++

Department of Medicine,

++

University of California at San Diego,

++

San Diego, California [2, 7]

++
++

Kenneth C. Anderson, MD

++

Kraft Family Professor of Medicine,

++

Harvard Medical School;

++

Chief, Jerome Lipper Multiple Myeloma Center,

++

Dana-Farber Cancer Institute,

++

Boston, Massachusetts [12, 18]

++
++

Frederick R. Appelbaum, MD

++

Director, Division of Clinical Research,

++

Fred Hutchinson Cancer Research Center,

++

Seattle, Washington [31]

++
++

Valder R. Arruda, MD, PhD

++

Associate Professor,

++

Division of Hematology,

++

Department of Pediatrics,

++

Perelman School of Medicine,

++

University of Pennsylvania,

++

Philadelphia, Pennsylvania [21]

++
++

Robert S. Benjamin, MD

++

P. H. and Faye E. Robinson Distinguished Professor of Medicine,

++

Department of Sarcoma Medical Oncology,

++

The University of Texas M.D. Anderson Cancer Center,

++

Houston, Texas [47]

++
++

Edward J. Benz, Jr., MD

++

Richard and Susan Smith Professor of Medicine;

++

Professor of Genetics, Harvard Medical School;

++

President and CEO, Dana-Farber Cancer Institute;

++

Director and Principal Investigator,

++

Dana-Farber/Harvard Cancer Center;

++

Boston, Massachusetts [8]

++
++

John L. Berk, MD

++

Associate Professor of Medicine,

++

Boston University School of Medicine;

++

Clinical Director, Amyloidosis Center,

++

Boston Medical Center,

++

Boston, Massachusetts [19]

++
++

Clara D. Bloomfield, MD

++

Distinguished University Professor;

++

William G. Pace, III Professor of Cancer Research;

++

Cancer Scholar and Senior Advisor,

++

The Ohio State University Comprehensive Cancer Center;

++

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,

++

Columbus, Ohio [14]

++
++

George J. Bosl, MD

++

Professor of Medicine,

++

Weill Cornell Medical College;

++

Chair, Department of Medicine;

++

Patrick M. Byrne Chair in Clinical Oncology,

++

Memorial Sloan-Kettering Cancer Center,

++

New York, New York [45]

++
++

Otis W. Brawley, MD, FACP

++

Professor of Hematology,

++

Medical Oncology, Medicine and Epidemiology,

++

Emory University; Chief Medical and Scientific Officer,

++

American Cancer Society, Atlanta, Georgia [28]

++
++

Cynthia D. Brown, MD

++

Associate Professor of Clinical Medicine,

++

Division of Pulmonary, Critical Care,

++

Sleep and Occupational Medicine Indiana University,

++

Indianapolis, Indiana [Review and Self-Assessment]

++
++

Brian I. Carr, MD, PhD, FRCP

++

IRCCS de Bellis National Center for GI Diseases,

++

Castellana Grotte, BA, Italy [41]

++
++

Jeffrey W. Clark, MD

++

Associate Professor of Medicine,

++

Harvard Medical School; Medical Director,

++

Clinical Trials Core, Dana-Farber Harvard Cancer Center;

++

Massachusetts General Hospital,

++

Boston, Massachusetts [26]

++
++

Francis S. Collins, MD, PhD

++

Director, National Institutes of Health,

++

Bethesda, Maryland [25]

++
++

Jorge Cortes, MD

++

D. B. Lane Cancer Research Distinguished Professor for Leukemia Research;

++

Deputy Chairman; Section Chief of AML and CML,

++

The University of Texas M.D. Anderson Cancer Center,

++

Houston, Texas [15]

++
++

Jennifer M. Croswell, MD, MPH

++

Medical Officer,

++

Center for Oncology Prevention Trials Research Group,

++

Division of Cancer Prevention, National Cancer Institute,

++

Bethesda, Maryland [28]

++
++

David Cunningham, MD, MB, ChB, FRCP

++

Professor, Head of Gastrointestinal/Lymphoma Unit;

++

Director of Clinical Research,

++

Royal Marsden NHS Trust,

++

London, United Kingdom [42]

++
++

Brendan D. Curti, MD

++

Director, Biotherapy Program,

++

Robert W. Franz Cancer

++

Research Center,

++

Providence Portland Medical Center,

++

Portland, Oregon [34]

++
++

Josep Dalmau, MD, PhD

++

ICREA Professor,

++

Institut d'Investigació Biomèdica August

++

Pi i Sunyer,

++

University of Barcelona, Barcelona,

++

Spain; Adjunct

++

Professor, University of Pennsylvania,

++

Philadelphia, Pennsylvania [55]

++
++

Lisa M. DeAngelis, MD

++

Professor of Neurology,

++

Weill Cornell Medical College;

++

Chair, Department of Neurology,

++

Memorial Sloan Kettering Cancer Center,

++

New York, New York [48]

++
++

Janice P. Dutcher, MD

++

Associate Director,

++

Cancer Research Foundation of New York,

++

Chappaqua, New York; Former Professor,

++

New York Medical College,

++

Valhalla, New York [56]

++
++

Jeffrey S. Dzieczkowski, MD

++

Physician, St. Alphonsus Regional Medical Center;

++

Medical Director, Coagulation Clinic,

++

Saint Alphonsus Medical Group,

++

International Medicine and Travel Medicine,

++

Boise, Idaho [12]

++
++

James A. Eastham, MD

++

Chief, Urology Service,

++

Florence and Theodore Baumritter/Enid Ancell Chair of Urologic Oncology,

++

Department of Surgery,

++

Sidney Kimmel Center for Prostate and Urologic Cancers,

++

Memorial Sloan Kettering Cancer Center,

++

New York, New York [44]

++
++

Ezekiel J. Emanuel, MD, PhD

++

Chair, Department of Medical Ethics and Health Policy,

++

Levy University Professor,

++

Perelman School of Medicine and Wharton School,

++

University of Pennsylvania,

++

Philadelphia, Pennsylvania [33]

++
++

Darren R. Feldman, MD

++

Associate Professor in Medicine,

++

Weill Cornell Medical Center;

++

Assistant Attending, Genitourinary Oncology Service,

++

Memorial Sloan-Kettering Cancer Center,

++

New York, New York [45]

++
++

Robert W. Finberg, MD

++

Chair, Department of Medicine,

++

University of Massachusetts Medical School,

++

Worcester, Massachusetts [30]

++
++

Jane E. Freedman, MD

++

Professor of Medicine,

++

University of Massachusetts Medical School,

++

Worcester, Massachusetts [22]

++
++

Carl E. Freter, MD, PhD, FACP

++

Professor of Medicine;

++

Director, Division of Hematology and Oncology;

++

Associate Director, Cancer Center,

++

Saint Louis University, St. Louis, Missouri [56]

++
++

John I. Gallin, MD

++

Director, Clinical Center,

++

National Institutes of Health,

++

Bethesda, Maryland [5]

++
++

Samuel Z. Goldhaber, MD

++

Professor of Medicine,

++

Harvard Medical School;

++

Director, Thrombosis Research Group,

++

Brigham and Women's Hospital,

++

Boston, Massachusetts [23]

++
++

Michael F. Greene, MD

++

Professor of Obstetrics,

++

Gynecology and Reproductive Biology,

++

Harvard Medical School;

++

Vincent Department of Obstetrics and Gynecology,

++

Massachusetts General Hospital,

++

Boston, Massachusetts [32]

++
++

Rasim Gucalp, MD

++

Professor of Clinical Medicine,

++

Albert Einstein College of Medicine;

++

Associate Chairman for Educational Programs,

++

Department of Oncology;

++

Director, Hematology/Oncology Fellowship,

++

Montefiore Medical Center,

++

Bronx, New York [56]

++
++

Patrick H. Henry, MD

++

Clinical Adjunct Professor of Medicine,

++

University of Iowa,

++

Iowa City, Iowa [4]

++
++

Katherine A. High, MD

++

William H. Bennett Professor of Pediatrics,

++

Perelman School of Medicine,

++

University of Pennsylvania;

++

Investigator, Howard Hughes Medical Institute,

++

The Children's Hospital of Philadelphia,

++

Philadelphia, Pennsylvania [21]

++
++

A. Victor Hoffbrand, DM

++

Emeritus Professor of Haematology,

++

University College, London;

++

Honorary Consultant Haematologist,

++

Royal Free Hospital,

++

London, United Kingdom [9]

++
++

Steven M. Holland, MD

++

Chief, Laboratory of Clinical Infectious Diseases,

++

National Institute of Allergy and Infectious Diseases,

++

National Institutes of Health,

++

Bethesda, Maryland [5]

++
++

Leora Horn, MD, MSc

++

Assistant Professor,

++

Division of Hematology and Medical Oncology,

++

Vanderbilt University School of Medicine,

++

Nashville, Tennessee [36]

++
++

Brian Houston, MD

++

Division of Cardiology,

++

Department of Medicine,

++

Johns Hopkins Hospital,

++

Baltimore, Maryland [Review and Self-Assessment]

++
++

J. Larry Jameson, MD, PhD

++

Robert G. Dunlop Professor of Medicine;

++

Dean, Perelman School of Medicine at the University of Pennsylvania;

++

Executive Vice President,

++

University of Pennsylvania for the Health System,

++

Philadelphia, Pennsylvania [50, 54]

++
++

Robert T. Jensen, MD

++

Chief, Cell Biology Section,

++

National Institutes of Diabetes,

++

Digestive and Kidney Diseases,

++

National Institutes of Health,

++

Bethesda, Maryland [51]

++
++

David H. Johnson, MD

++

Donald W. Seldin Distinguished Chair in Internal Medicine;

++

Professor and Chairman,

++

Department of Internal Medicine,

++

University of Texas Southwestern School of Medicine,

++

Dallas, Texas [36]

++
++

Hagop Kantarjian, MD

++

Chairman, Leukemia Department;

++

Professor of Leukemia,

++

The University of Texas M.D. Anderson Cancer Center,

++

Houston, Texas [15]

++
++

Barbara A. Konkle, MD

++

Professor of Medicine, Hematology,

++

University of Washington; Director,

++

Translational Research, Puget Sound Blood Center,

++

Seattle, Washington [3, 20]

++
++

Barnett S. Kramer, MD, MPH, FACP

++

Director, Division of Cancer Prevention,

++

National Cancer Institute,

++

Bethesda, Maryland [28]

++
++

Marc E. Lippman, MD, MACP, FRCP

++

Kathleen and Stanley Glaser Professor,

++

Department of Medicine, Deputy Director,

++

Sylvester Comprehensive Cancer Center,

++

University of Miami Miller School of Medicine,

++

Miami, Florida [38]

++
++

Dan L. Longo, MD

++

Professor of Medicine,

++

Harvard Medical School;

++

Senior Physician, Brigham and Women's Hospital;

++

Deputy Editor, New England Journal of Medicine,

++

Boston, Massachusetts [1, 2, 4, 6, 16-18, 26, 27, 29, 32, 37, 53, 54, 57]

++
++

Joseph Loscalzo, MD, PhD

++

Hersey Professor of the Theory and Practice of Medicine,

++

Harvard Medical School;

++

Chairman, Department of Medicine;

++

Physician-in-Chief, Brigham and Women's Hospital,

++

Boston, Massachusetts [22]

++
++

Christine M. Lovly, MD, PhD

++

Academic, Vanderbilt Ingram Cancer Center,

++

Vanderbilt University School of Medicine,

++

Nashville, Tennessee [36]

++
++

Lucio Luzzatto, MD, FRCP, FRCPath

++

Professor of Hematology,

++

University of Genova, Genova;

++

Scientific Director, Istituto Toscano Tumori,

++

Florence, Italy [10]

++
++

Susan J. Mandel, MD, MPH

++

Professor of Medicine;

++

Associate Chief, Division of Endocrinology,

++

Diabetes and Metabolism, Perelman School of Medicine,

++

University of Pennsylvania,

++

Philadelphia, Pennsylvania [50]

++
++

Guido Marcucci, MD

++

Professor of Medicine;

++

John B. and Jane T. McCoy Chair in Cancer Research;

++

Associate Director of Translational Research,

++

Comprehensive Cancer Center,

++

The Ohio State University College of Medicine,

++

Columbus, Ohio [14]

++
++

Robert J. Mayer, MD

++

Faculty Vice President for Academic Affairs,

++

Dana-Farber Cancer Institute;

++

Stephen B. Kay Family Professor of Medicine,

++

Harvard Medical School,

++

Boston, Massachusetts [39, 40]

++
++

Pat J. Morin, PhD

++

Senior Director,

++

Scientific Review and Grants Administration,

++

American Association for Cancer Research,

++

Philadelphia, Pennsylvania [25]

++
++

Robert J. Motzer, MD

++

Professor of Medicine,

++

Joan and Sanford Weill College of Medicine of Cornell University D. Attending Physician,

++

Genitourinary Oncology Service,

++

Memorial Sloan-Kettering Cancer Center,

++

New York, New York [43, 45]

++
++

Nikhil C. Munshi, MD

++

Professor of Medicine,

++

Harvard Medical School;

++

Boston VA Healthcare System;

++

Director of Basic and Correlative Sciences;

++

Associate Director, Jerome Lipper Myeloma Center,

++

Dana-Farber Cancer Institute,

++

Boston, Massachusetts [18]

++
++

Hartmut P. H. Neumann, MD

++

Universitaet Freiburg,

++

Medizinische Universitaetsklinik,

++

Freiburg im Breisgau, Germany [53]

++
++

Shreyaskumar R. Patel, MD

++

Robert R. Herring

++

Distinguished Professor of Medicine;

++

Center Medical Director,

++

Sarcoma Center,

++

The University of Texas M.D. Anderson Cancer Center,

++

Houston, Texas [47]

++
++

Jonathan E. Rosenberg, MD

++

Associate Attending;

++

Section Chief, Non-Prostate Program,

++

Division of Solid Tumor Oncology,

++

Department of Medicine,

++

Memorial Sloan-Kettering Cancer Center,

++

New York, New York [43]

++
++

Myrna R. Rosenfeld, MD, PhD

++

Department of Neurology,

++

Hospital Clínic/IDIBAPS,

++

Barcelona, Spain [55]

++
++

Edward A. Sausville, MD, PhD

++

Professor of Medicine,

++

University of Maryland School of Medicine;

++

Associate Director for Clinical Research,

++

Marlene and Stewart Greenbaum Cancer Center,

++

Baltimore, Maryland [29]

++
++

David T. Scadden, MD

++

Gerald and Darlene Professor of Medicine;

++

Co-Chair, Harvard Stem Cell Institute;

++

Co-chair, Department of Stem Cell and Regenerative Biology,

++

Harvard Medical School;

++

Director, Center for Regenerative Medicine;

++

Chief, Hematologic Malignancies, Cancer Center,

++

Massachusetts General Hospital, Boston, Massachusetts [1]

++
++

Howard I. Scher, MD

++

Professor of Medicine,

++

Joan and Sanford Weill College of Medicine of Cornell University;

++

D. Wayne Calloway Chair in Urologic Oncology;

++

Attending Physician and Chief, Genitourinary Oncology Service,

++

Department of Medicine,

++

Memorial Sloan-Kettering Cancer Center,

++

New York, New York [43, 44]

++
++

Michael V. Seiden, MD, PhD

++

Chief Medical Officer,

++

McKesson Specialty Health,

++

The Woodlands, Texas [46]

++
++

David C. Seldin, MD, PhD

++

Professor, Departments of Medicine and Microbiology;

++

Chief, Section of Hematology-Oncology;

++

Director, Amyloidosis Center,

++

Boston University School of Medicine;

++

Boston Medical Center,

++

Boston, Massachusetts [19]

++
++

Elizabeth Smyth, MB BAO, MSc

++

Department of Gastrointestinal Oncology,

++

Royal Marsden NHS Foundation Trust,

++

London and Sutton, United Kingdom [42]

++
++

Jerry L. Spivak, MD

++

Professor of Medicine and Oncology,

++

Hematology Division,

++

Johns Hopkins University School of Medicine,

++

Baltimore, Maryland [13]

++
++

Ayalew Tefferi, MD

++

Professor of Medicine and Hematology,

++

Mayo Clinic, Rochester, Minnesota [17]

++
++

Rajesh V. Thakker, MD, FMedSci, FR

++

May Professor of Medicine,

++

Academic Endocrine Unit,

++

University of Oxford; O.C.D.E.M.,

++

Churchill Hospital, Headington, Oxford, United Kingdom [52]

++
++

Jeffrey M. Trent, PhD, FACMG

++

President and Research Director,

++

Translational Genomics Research Institute,

++

Phoenix, Arizona;

++

Van Andel Research Institute,

++

Grand Rapids, Michigan [25]

++
++

Walter J. Urba, MD, PhD

++

Director of Research,

++

Earle A. Chiles Research Institute,

++

Providence Cancer Center, Portland, Oregon [34]

++
++

Gauri R. Varadhachary, MD

++

Professor,

++

Department of Gastrointestinal Medical Oncology,

++

The University of Texas M.D. Anderson Cancer Center,

++

Houston, Texas [49]

++
++

Bert Vogelstein, MD

++

Investigator, Howard Hughes Medical Institute;

++

Director, Ludwig Center at the Sidney Kimmel Comprehensive Cancer Center;

++

Clayton Professor of Oncology and Pathology;

++

Johns Hopkins Medical Institutions,

++

Baltimore, Maryland [25]

++
++

Everett E. Vokes, MD

++

John E. Ultmann Professor;

++

Chairman, Department of Medicine;

++

Physician-in-Chief, University of Chicago Medical Center,

++

Chicago, Illinois [35]

++
++

Anthony P. Weetman, MD, DSc

++

University of Sheffield,

++

School of Medicine Sheffield,

++

United Kingdom [50]

++
++

Jeffrey I. Weitz, MD, FRCP(C), FACP

++

Professor of Medicine and Biochemistry,

++

McMaster University; Executive Director,

++

Thrombosis and Atherosclerosis Research Institute,

++

Hamilton, Ontario, Canada [24]

++
++

Patrick Y. Wen, MD

++

Professor of Neurology,

++

Harvard Medical School; Director,

++

Center for Neuro-Oncology, Dana-Farber Cancer Institute;

++

Director, Division of Neuro-Oncology, Department of Neurology,

++

Brigham and Women's Hospital;

++

Dana-Farber Cancer Institute, Boston, Massachusetts [48]

++
++

Charles M. Wiener, MD

++

Vice President of Academic Affairs,

++

Johns Hopkins Medicine International,

++

Professor of Medicine and Physiology,

++

Johns Hopkins School of Medicine,

++

Baltimore, Maryland [Review and Self-Assessment]

++
++

Neal S. Young, MD

++

Chief, Hematology Branch,

++

National Heart, Lung and Blood Institute;

++

Director, NIH Center for Human Immunology,

++

Autoimmunity and Inflammation,

++

National Institutes of Health,

++

Bethesda, Maryland [11]

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.